Targeted Protein Degradation and Beyond: Integrated Biological, Chemical and Computational Approaches to Proximity-Based Modulation

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: closed (31 March 2026) | Viewed by 932

Special Issue Editors


E-Mail Website
Guest Editor
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 17, I-90128 Palermo, Italy
Interests: medicinal chemistry; bioactive heterocyclic compounds; computer-aided drug design; targeted cancer therapy; molecular modeling; organic synthesis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 17, I-90128 Palermo, Italy
2. NBFC, National Biodiversity Future Center, Piazza Marina 61, 90133 Palermo, Italy
Interests: medicinal chemistry; computational approaches, computer-aided drug design; targeted cancer therapy; molecular modeling; drug development; in silico; breast cancer; design and synthesis; anticancer early drug discovery; covalent inhibition
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The proximity-induced modulation of protein function is revolutionizing drug discovery, enabling control over previously undruggable targets. Rather than acting through classical inhibition, approaches like PROTACs, molecular glues, DUBTACs, LYTACs, and stabilizers induce proximity between proteins to trigger degradation, stabilization, or altered signalling. These strategies are opening new therapeutic avenues in cancer, neurodegeneration, and immune regulation. Designing such molecules demands a multidisciplinary effort spanning medicinal chemistry, chemical biology, and computational modelling. Critical challenges include identifying suitable recruiter elements (e.g., E3 ligases), optimizing linkers for ternary complex formation, and predicting degradation efficiency via in silico tools. Proximity-based drug discovery exemplifies the potential of integrated research. This Special Issue welcomes contributions that focus on the following:

  • Design and synthesis of PROTACs, molecular glues, and related platforms;
  • AI-assisted degrader design;
  • Novel recruiter element discovery;
  • SAR studies and linker optimization;
  • Molecular modelling of ternary complexes;
  • Mechanistic studies in chemical biology.

We invite original research, reviews, and perspectives—experimental or theoretical—that explore these emerging areas. By integrating insights from chemistry, biology, and computation, this Special Issue aims to accelerate innovation in proximity-based therapeutic strategies.

Dr. Gabriele La Monica
Prof. Antonino Lauria
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • PROTACs
  • protein degradation
  • drug discovery
  • chemical biology
  • ternary complex
  • undruggable targets

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 3540 KB  
Article
Targeted Removal of HCV E2 N2 N-Glycan Is Associated with Improved Immune Responses in Mice
by Yuan-Qin Min, Yu-Shan Ren, Wen-Wen Zhang, Yi-Dan Zhou and Min Liu
Biomolecules 2026, 16(2), 183; https://doi.org/10.3390/biom16020183 - 24 Jan 2026
Viewed by 613
Abstract
Hepatitis C virus (HCV) still lacks a licensed vaccine. The envelope glycoprotein E2 is a key neutralizing target, but its dense N-glycan shield can hinder epitope exposure. In this study, we revisit E2 glycan editing and examine whether single-site deletion preserves antigen integrity [...] Read more.
Hepatitis C virus (HCV) still lacks a licensed vaccine. The envelope glycoprotein E2 is a key neutralizing target, but its dense N-glycan shield can hinder epitope exposure. In this study, we revisit E2 glycan editing and examine whether single-site deletion preserves antigen integrity while improving immune responses in mice under a DNA immunization setting. Using a secreted E2 ectodomain (sE2384–661), we generated five N to D mutants at conserved sites (N1, N2, N4, N6, and N11) and evaluated them in a unified DNA immunization model with identical CpG content and delivery conditions across groups. The N2 mutant (N423, sE2-N2) maintained expression, secretion, and ER localization; furthermore, in mice, it was associated with higher anti-E2 titers and greater inhibition of H77 (genotype 1a) HCVcc at the tested dilutions, with limited activity against Con1 (1b). Cellular analyses showed increased IFN-γ ELISPOT counts and higher frequencies of granzyme B+/perforin+ CD8+ T cells after N2 immunization, while IL-4 remained low. Functionally, N2 elicited stronger specific lysis of CT26-sE2 targets in vitro and slowed CT26-sE2 tumor growth in vivo. In HCV-infected ICR4R+ mice, therapeutic vaccination with sE2-N2 reduced blood HCV RNA and hepatic readouts compared with sE2. A monoclonal antibody isolated from sE2-N2-immunized mice (1C1) neutralized HCVcc in vitro and, after passive transfer, lowered viremia and liver signals in infected mice. Collectively, these findings indicate that selective removal of the N2 glycan preserves antigen properties and is associated with improved humoral and cellular immunity and measurable in vivo activity, supporting targeted glycan editing as a practical strategy to refine E2-based HCV vaccines. Full article
Show Figures

Figure 1

Back to TopTop